Ryan Weight, DO discusses takeaways from the Immuno-Oncology Institute Working Group Summit. The summit was a part of the Association of Community Cancer Centers’ Immuno-Oncology Institute and brought together multidisciplinary working groups to strategize policy and delivery changes for the effective use of immunotherapy.
Ryan Weight, DO, an assistant professor of medicine, University of Colorado Health Cancer Center, discusses takeaways from the 2018 Immuno-Oncology Institute Working Group Summit. The summit was a part of the Association of Community Cancer Centers’ Immuno-Oncology Institute and brought together multidisciplinary working groups to strategize policy and delivery changes for the effective use of immunotherapy. Weight shares knowledge around the 4 working groups of physicians, nurses, mid-level providers, and healthcare administrators who aim to understand and address the issues related to immuno-oncology (IO) care.
Within 2 of the working groups at the summit, the participants discussed the role of big data and telemedicine in IO. Another working group focused on care, education, and coordination. The fourth working group examined the role of multispecialty care in IO.
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More